Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STA... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STATUS FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB + VENETOCLAX IN THE HOVON 141/VISION TRIAL
0
Authors
Aleksandra Urban
20 more
Aleksandra Urban
•
Johanne Hermansen
18 more
•
Sigrid Skånland
Published
August 1, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
HemaSphere
Topics
Medicine
Cancer Oncology
Internal Medicine
Genetics
Pathology And Forensic Medicine
Show all topics
DOI
10.1097/01.hs9.0000967488.92046.ec
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
HemaSphere
Topics
Medicine
Cancer Oncology
Internal Medicine
Genetics
Pathology And Forensic Medicine
Show all topics
DOI
10.1097/01.hs9.0000967488.92046.ec
License
CC-BY-NC-ND
